Exam 3 Flashcards
Biofuels: Ethanol
Fermentation of sugars (corn, sugarcane) by yeast to produce alcohol.
Biofuels: Biodiesel
Transesterification of fats/oils with alcohol (e.g., methanol) to produce methyl esters
(biodiesel) and glycerol.
Biofuels: Bio gas
Anaerobic digestion of organic waste by bacteria, producing methane.
Biofuels: Algae-based
Harvesting lipids from algae and processing them into biofuel.
Biofuels: Cellulosic
Breaking down cellulose from plant materials into fermentable sugars via
enzymatic hydrolysis.
Biofuels
Biofuels are renewable fuels derived from biological materials such as plants, algae, or waste.
Transportation, heating, electricity
Bacteriophage Build
Head (contains DNA/RNA)
Collar
Tail (injects genetic material into host cell)
Tail Fibre (Specificity of phage is given by the proteins that are encoded in the tail fibre)
Bacteriophages Lytic Life Cycle
DNA injected as dsDNA, then converted to circular DNA; DNA fed to each head, tail attached to host cell is lysed; more cells infected / faster acting
Bacteriophage single cell
Lytic Cycle, Lysogeny/ carrier site, Chronic Infection
Bacteriophage population
what happens to the phages in our gastrointestinal tract. The health of our
microbiome is partly determined by the phages we have.
Steps in generation of scFv using phage display system
i. Isolate mRNA from B cells from immunized mice or infected/recovered Covid-19 individuals or use hybridomas secreting Mabs of know specificity
ii. Convert to cDNA and PCR amplify using degenerate primers to capture the VH and VL chains repertoire
iii. Clone PCR fragments into phagemid vector pComb 3
iv. Infect compatible strains of E. coli with the phagemid. Infect with helper phage to obtain
intact phage particles expressing VH and VL chains
v. Identify the phage particles of interest by panning using antigen or other substrates of
interest
vi. Convert phage DNA from particles of interest into plasmid DNA by restriction enzyme
digestion and relegation.
vii. Re-transform appropriate strains of E. coli for expression of soluble scFv specific to
antigen of choice
viii. Similar strategies can be used for expression of IgGs
How would you engineer a primer against SARS-COV2
i. Engineer restriction enzymes sites based on final destination expression plasmid
ii. Engineer linker sequence at appropriate ends of VL and VH amplicons
iii. Engineer FLAG tag or 6X- Histidine-specific sequence
iv. Engineer overlap sequence on appropriate ends of VL and VH amplicons for overlap PCR
and fragment assembly
v. Incorporate degeneracy as needed for obtaining the variable regions sequences
vi. If the primers are directed at VL and VH regions of antibodies from B cells from Covid-19 convalescent individuals – you are likely to express neutralizing antibodies against one or more proteins of SARS-CoV-2.
Live/Attenuated Virus
Cons
Requires immune system activation,
Reversion of virulence in bacteria,
Benefit
Longer lasting, greater immune response,
Reduce the need for boosters, do not require adjuvants,
produced at relatively low cost, and can be administered not just through IV, but orally.
Recombinant
Cons
require booster shots,
Benefit
Could be used for immunocompromised,
Strong immune response (not as much as attenuated),
greater stability for transportation.
Inactivated
Cons
less immune response,
requires boosters,
may increase allergic reaction,
Benefit
Cannot revert virulence in bacteria,
fewer side effects,
easy storage.